Resero partnership boosts data reports for Charles River clients

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/ipopba)
(Image: Getty/ipopba)

Related tags: Charles river laboratories, Charles river, Resero, Research

Charles River Laboratories becomes the exclusive CRO partner for Resero’s nonclinical data report generation tool TurboToxicology.

Charles River Laboratories​ announced the collaboration as part of an investment in Resero Analytics, a developer of data and software solutions for pharmaceutical companies, CROs and regulators.

TurboToxicology, a software tool that analyzes nonclinical data, conducts statistical analyses, applies proprietary algorithms and then formats the data into written reports.

With the use of TurboToxicology, Charles River hopes to accelerate its clients’ access to the reports required for the drug development process before they move on to submissions for Investigational New Drug (IND) or New Drug Approvals (NDA).

“Our goal is to give our clients the gift of time by alleviating some of the upfront administrative work,”​ said Birgit Girshick, corporate executive VP of Discovery and Safety Assessment, Biologics Testing Solutions at Charles River.

Pam Walker, corporate VP of Data and Report Delivery Services and Business Optimization at Charles River told us that TurboToxicology, “utilizes a proprietary algorithm to determine importance of findings and conduct statistical analyses while providing a user-friendly interface for our scientific staff,” ​Walker noted.

Financial details of the agreement were not disclosed.

Related news

Show more

Related products

show more

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us

Products

View more

Webinars